Finerenone - Halting Relative Hyperaldosteronism in Chronic Kidney Disease

N Engl J Med. 2020 Dec 3;383(23):2285-2286. doi: 10.1056/NEJMe2031382. Epub 2020 Oct 23.

Authors

Julie R Ingelfinger¹, Clifford J Rosen¹

Affiliation

¹ From Tufts University School of Medicine, Boston, and the Center for Clinical and Translational Research, Maine Medical Center Research Institute, Scarborough (C.J.R.).

PMID: 33095527
DOI: 10.1056/NEJMe2031382

No abstract available

Publication types

Editorial
Comment

MeSH terms

Diabetes Mellitus, Type 2*
Family
Humans
Hyperaldosteronism*
Mineralocorticoid Receptor Antagonists
Naphthyridines
Renal Insufficiency, Chronic*

Substances

Mineralocorticoid Receptor Antagonists
Naphthyridines
finerenone